En la selección de artículos colaboró la Dra. Cristina Fernández Barrantes
AMERICAN JOURNAL OF HEALTH SYSTEM PHARMACY 2020 77 (12)
1. A multicenter quality improvement initiative on the impact of pharmacists’ postdischarge follow-up toreduce medication-related acute care episodes. Pág. 938-942.
2. Evaluating the effects of a multidisciplinary transition care management program on hospital readmissions. Pág. 931-937.
3. Effects of pharmacy interventions at transitions of care on patient outcomes. Pág. 943-949.
4. Evaluation of a multidisciplinary approach to reduce internal medicine readmissions using a readmission prediction index. Pág. 950-957.
5. Improving transitions of care for critically ill adult patients on pulmonary arterial hypertension medications. Pág. 958-965.
6. Pharmacist-led transitions-of-care program reduces 30-day readmission rates for Medicare patients in a large health system. Pág. 972-978.
AMERICAN JOURNAL OF HEALTH SYSTEM PHARMACY 2020 77 (11)
7. Therapeutic monitoring of vancomycin for serious methicillin-resistant staphylococcus aureus infections : a revised consensus guideline and review by the American Society of Health-System Pharmacists, the infectious diseases society of America the Pediatric Infections Disease Society, and the society of infectious diseases pharmacists. Pág . 835-863.
8. Direct-acting oral anticoagulant use at extremes of body weight: Literature review and recommendations. Pág. 865-876.
9. Pharmacokinetics of linezolid for methicillin-resistant Staphylococcus aureus pneumonia in an adult receiving extracorporeal membrane oxygenation .Pág. 877-881.
10. Long-term stability of ready-to-use 1-mg/mL midazolam solution. Pág. 681-689.
11. Safety of intravenous push administration of beta-lactams within a healthcare system. Pág. 701-708.
AMERICAN JOURNAL OF HEALTH SYSTEM PHARMACY 2020 77 (10)
12. A physician-pharmacist collaborative care model to prevent opioid misuse 771-780
13. Procalcitonin in special patient populations: Guidance for antimicrobial therapy. Pág. 745-758.
14. Involvement of pharmacist-reviewed urine cultures and sexually transmitted infections in the emergency department reduces time to antimicrobial optimization. Pág. Supl 2. S54-S59.
COVID-19 AMERICAN JOURNAL OF HEALTH SYSTEM PHARMACY
15. Implementation of field hospital pharmacy services during the COVID-19 pandemic.
16. Maintaining comprehensive pharmacy services during a pandemic: recommendations from a designated COVID-19 facility.
17. COVID-19 pandemic preparedness: A practical guide from an operational pharmacy perspective.
18. Pharmacy services at a temporary COVID-19 hospital in Wuhan, China.
19. Surviving the surge: Evaluation of early impact of COVID-19 on inpatient pharmacy services at a community teaching hospital.
20. Minimizing pharmacotherapy-related healthcare worker exposure to SARS-CoV-2.
21. Establishing clinical pharmacist telehealth services during the COVID-19 pandemic.
22. COVID-19 pandemic planning, response, and lessons learned at a community hospital.
23. Assessment of Evidence for COVID-19-Related Treatments: Updated
CURRENT OPINION PHARMACOLOGY 2020 53
24. Potential of glucocorticoids to treat intestinal inflammation during sepsis. Pág.1-7.
25. Impact of gut microbiota on neurogenesis and neurological diseases during infancy. Pág. 33-37.
26. Anti-inflammatory glucocorticoid action: genomic insights and emerging concepts. Pág. 35-44.
CURRENT OPINION PHARMACOLOGY 2020 50
27. Endocannabinoid system and adult neurogenesis: a focused review. Pág. 25-32.
NEW ENGLAND JOURNAL OF MEDICINE 2020 382 (23)
28. Enzalutamide and Survival in Nonmetastatic,Castration-Resistant Prostate Cancer. Pág. 2197-2206
NEW ENGLAND JOURNAL OF MEDICINE 2020 382 (24)
29 .Compassionate Use of Remdesivir for Patients with Severe Covid-19 Pág. 2327-2336.
30. Disseminated Coccidioidomycosis Treated with Interferon-γ and Dupilumab. Pág.2337-2336